SELLAS Life Sciences Group, Inc. — Director's Dealing 2019

Mar 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELLAS Life Sciences Group, Inc. (SLS)
CIK: 0001390478
Period of Report: 2019-03-14

Reporting Person: Burns John Thomas (VP, Finance & Corp Controller)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-14	Stock Option (Right to Buy)	$1.38	A	90000	Acquired	2029-03-14	Common Stock (90000)	Direct

Footnotes

F1: One-quarter (1/4) of the option shares will vest and became exercisable one year from the March 14, 2019 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.